Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for poor-prognosis cervicofacial lymphatic malformations
2013-002800-15Phase 2Active
- Sponsor
- CHU de Lille
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sirolimus in lymphangioma and cystic hygroma (CH), sponsored by CHU de Lille. Started Sep 2015; status: active.
02
Drugs
sirolimus
03
Conditions
lymphangiomacystic hygroma (CH)
Beyond the preview
Go deeper on 2013-002800-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002800-15.